BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29270698)

  • 1. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Hoshino N; Ganeko R; Hida K; Sakai Y
    Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.
    Hoshino N; Hida K; Ganeko R; Sakai Y
    Int J Colorectal Dis; 2017 May; 32(5):737-740. PubMed ID: 27889823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
    Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy.
    Cascella M; Muzio MR
    J Integr Med; 2017 Mar; 15(2):77-87. PubMed ID: 28285612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
    Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
    BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis.
    Sato MT; Hasegawa T; Noma H; Sugita H; Ota E
    BMJ Open; 2023 Sep; 13(9):e070645. PubMed ID: 37699621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
    Chow R; Novosel M; So OW; Bellampalli S; Xiang J; Boldt G; Winquist E; Lock M; Lustberg M; Prsic E
    BMJ Support Palliat Care; 2023 Mar; 13(1):27-34. PubMed ID: 36194493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
    Hirayama Y; Yoshida Y; Mori M; Tamura K
    Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.
    Teng C; Cohen J; Egger S; Blinman PL; Vardy JL
    Support Care Cancer; 2022 Jan; 30(1):33-47. PubMed ID: 34410459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
    Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y
    Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of vitamin E on chemotherapy-induced peripheral neuropathy: a meta-analysis of randomized controlled trials.
    Eum S; Choi HD; Chang MJ; Choi HC; Ko YJ; Ahn JS; Shin WG; Lee JY
    Int J Vitam Nutr Res; 2013; 83(2):101-11. PubMed ID: 24491883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.
    Li K; Giustini D; Seely D
    Curr Oncol; 2019 Apr; 26(2):e147-e154. PubMed ID: 31043820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
    Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
    J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
    Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
    Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Vitamin E on Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled Trials.
    Miao H; Li R; Chen D; Hu J; Chen Y; Xu C; Wen Z
    Ann Nutr Metab; 2021; 77(3):127-137. PubMed ID: 34148036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
    Ushio S; Kawashiri T; Egashira N
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.